ISSN: 1300-7777 E-ISSN: 1308-5263
An Extra Benefit of Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Lymphoblastic Lymphoma: Cure of Thalassemia Minor [Turk J Hematol]
Turk J Hematol. 2000; 17(2): 77-79

An Extra Benefit of Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Lymphoblastic Lymphoma: Cure of Thalassemia Minor

Harika Çelebi1, Celalettin Üstün1, Mutlu Arat1, Hamdi Akan1, Gürol Tunçman2, Tayfun Özçelik2, Tayfun Özçelik2, H. Şenol Coşkun1, Haluk Koç1
1Department Of Hematology And Bone Marrow Transplant Unit, Ibn-i Sina Hospital, Ankara University, Ankara, Turkey
2Department Of Molecular Biology, Bilkent University, Ankara, Turkey

b thalassemia minor is frequent in mediterranean countries. It is a benign disorder and does not warrant any therapeutical intervention. We transplanted a 25-year-old Turkish male who was diagnosed as lymphoblastic lymphoma and had b thalassemia minor as well. He received peripheral blood stem cells transplantation from his HLA-identical sibling who was not a carrier of b thalassemia. After the allogeneic transplantation we did not only observe remission of the lymphoblastic lymphoma but also the disappearance of b thalassemia minor.

Keywords: b thalassemia minor, allogeneic peripheral blood stem cell transplantation, lymphoblastic lymphoma


Harika Çelebi, Celalettin Üstün, Mutlu Arat, Hamdi Akan, Gürol Tunçman, Tayfun Özçelik, Tayfun Özçelik, H. Şenol Coşkun, Haluk Koç. An Extra Benefit of Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Lymphoblastic Lymphoma: Cure of Thalassemia Minor. Turk J Hematol. 2000; 17(2): 77-79

Corresponding Author: Harika Çelebi, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2017) = 0.650